Gain Therapeutics (GANX) Change in Receivables (2020 - 2021)
Gain Therapeutics (GANX) posted quarterly Change in Receivables of -$24429.0 for Q4 2021, down 465.32% year-over-year from $6687.0 in Q4 2020, and up 92.56% quarter-over-quarter from -$328453.0 in Q3 2021.
Gain Therapeutics (GANX) Change in Receivables (2020 - 2021) Analysis & Trends
Gain Therapeutics' Change in Receivables history runs 2 years deep, the most recent figure standing at -$24429.0 for Q4 2021.
- In Q4 2021, Change in Receivables fell 465.32% year-over-year to -$24429.0; the TTM figure through Dec 2021 stood at -$8264.0 (down 4316.33% YoY), while the FY2021 annual figure was -$8264.0, down 4316.33% from the prior year.
- Change in Receivables for Q4 2021 stood at -$24429.0, up from -$328453.0 in the prior quarter.
- The five-year high for Change in Receivables was $513738.0 in Q1 2021, with the low at -$328453.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Gain Therapeutics | 85.97 Mn | 85.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -24,429.00 |
| Dec 31, 2021 | -24,429.00 |
| Sep 30, 2021 | -328,453.00 |
| Sep 30, 2021 | -328,453.00 |
| Jun 30, 2021 | -169,120.00 |
| Jun 30, 2021 | -169,120.00 |
| Mar 31, 2021 | 513,738.00 |
| Mar 31, 2021 | 513,738.00 |
| Dec 31, 2020 | 6,687.00 |
| Dec 31, 2020 | 6,687.00 |
| Sep 30, 2020 | -107,220.00 |
| Sep 30, 2020 | -107,220.00 |
| Jun 30, 2020 | 163,676.00 |
| Jun 30, 2020 | 163,676.00 |
| Mar 31, 2020 | -62,947.00 |
| Mar 31, 2020 | -62,947.00 |